Phapros Tbk PT
IDX:PEHA

Watchlist Manager
Phapros Tbk PT Logo
Phapros Tbk PT
IDX:PEHA
Watchlist
Price: 308 IDR 1.99% Market Closed
Market Cap: Rp258.7B

Operating Margin

-12.9%
Current
Declining
by 8.6%
vs 3-y average of -4.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-12.9%
=
Operating Income
Rp-110.1B
/
Revenue
Rp856.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-12.9%
=
Operating Income
Rp-110.1B
/
Revenue
Rp856.1B

Peer Comparison

Country Company Market Cap Operating
Margin
ID
Phapros Tbk PT
IDX:PEHA
258.7B IDR
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

Lower than 90% of companies in Indonesia
Percentile
10th
Based on 1 283 companies
10th percentile
-12.9%
Low
-111 644.7% — 0%
Typical Range
0% — 12.9%
High
12.9% — 524 864.9%
Distribution Statistics
Indonesia
Min -111 644.7%
30th Percentile 0%
Median 6.1%
70th Percentile 12.9%
Max 524 864.9%

Phapros Tbk PT
Glance View

Market Cap
258.7B IDR
Industry
Pharmaceuticals

PT Phapros Tbk is a pharmaceutical company, which engages in the production and marketing of pharmaceutical products. The company is headquartered in Jakarta Selatan, Dki Jakarta and currently employs 1,485 full-time employees. The company went IPO on 2018-12-26. The firm's medical devices include ACS MB system, ACS FB and FB PS, Primary Hip Stem, INASHUNT Semilunar Flushing, BoneFill Ortho and NPC-STRIP G. Its branded drugs include Colkatriol 0.25 mcg 30 Cap, DEXTROFEN S SYRUP 60ml, Diafac XR, Diafac 500 mg 10 tablets, Dextamine Syrup 60 ml, Diapros Tablet, Proinfarction, Pehavask 5 & 10, Spirolactone 25 & 100, Dios, anemone, Pladel, and others. The firm also operates calibration laboratory. The company offers medicines for cardiovascular & hematopoietic, gastrointestinal & hepatobiliary, hormone Genito, urinary endocrine & metabolic, vitamins & minerals nutrition, dermatology, local anesthesia, immune & allergy, and others.

PEHA Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-12.9%
=
Operating Income
Rp-110.1B
/
Revenue
Rp856.1B
What is Phapros Tbk PT's current Operating Margin?

The current Operating Margin for Phapros Tbk PT is -12.9%, which is below its 3-year median of -4.3%.

How has Operating Margin changed over time?

Over the last 3 years, Phapros Tbk PT’s Operating Margin has decreased from 7.4% to -12.9%. During this period, it reached a low of -27.6% on Dec 31, 2024 and a high of 8.2% on Mar 31, 2023.

Back to Top